AQR Capital Management LLC Boosts Holdings in Clover Health Investments, Corp. (NASDAQ:CLOV)

AQR Capital Management LLC grew its position in Clover Health Investments, Corp. (NASDAQ:CLOV) by 4.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 729,706 shares of the company’s stock after acquiring an additional 32,288 shares during the quarter. AQR Capital Management LLC owned about 0.15% of Clover Health Investments worth $898,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Jaffetilchin Investment Partners LLC raised its position in Clover Health Investments by 30.2% in the 1st quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company’s stock worth $39,000 after purchasing an additional 11,550 shares during the period. Vanguard Personalized Indexing Management LLC raised its holdings in shares of Clover Health Investments by 54.4% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company’s stock worth $42,000 after buying an additional 12,104 shares during the period. Viewpoint Capital Management LLC raised its holdings in shares of Clover Health Investments by 96.8% in the second quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company’s stock worth $38,000 after buying an additional 15,000 shares during the period. SignalPoint Asset Management LLC lifted its stake in shares of Clover Health Investments by 40.3% during the 1st quarter. SignalPoint Asset Management LLC now owns 139,366 shares of the company’s stock worth $111,000 after acquiring an additional 40,000 shares during the last quarter. Finally, Marshall Wace LLP purchased a new position in Clover Health Investments during the 2nd quarter valued at $55,000. Institutional investors own 19.77% of the company’s stock.

Clover Health Investments Price Performance

Shares of CLOV opened at $4.07 on Friday. The firm has a market capitalization of $2.02 billion, a price-to-earnings ratio of -15.07 and a beta of 2.13. Clover Health Investments, Corp. has a 1-year low of $0.61 and a 1-year high of $4.28. The company has a 50-day moving average of $2.91 and a 200 day moving average of $1.71.

Clover Health Investments (NASDAQ:CLOV) last issued its earnings results on Monday, August 5th. The company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.05. The business had revenue of $356.26 million for the quarter, compared to analyst estimates of $338.70 million. Clover Health Investments had a negative net margin of 7.30% and a negative return on equity of 36.55%. During the same period last year, the company posted ($0.06) earnings per share. On average, equities analysts anticipate that Clover Health Investments, Corp. will post -0.13 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, UBS Group started coverage on Clover Health Investments in a research note on Monday, October 7th. They issued a “neutral” rating and a $4.00 target price on the stock.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.